Recombinant UPF0283 membrane protein VP1870 (VP1870) is a protein product derived from the UPF0283 gene, which is expressed and purified using recombinant DNA technology. This protein is part of a family of uncharacterized proteins, and its specific function and role in biological systems are still under investigation. The recombinant form of this protein allows for its production in various host organisms, such as E. coli, yeast, insect cells, and mammalian cells, facilitating studies on its structure, function, and potential applications.
The expression of recombinant UPF0283 membrane protein VP1870 can be achieved in several host systems, each offering distinct advantages:
E. coli and Yeast: These hosts provide high yields and shorter turnaround times, making them ideal for large-scale production. They are particularly useful for producing proteins that do not require extensive post-translational modifications .
Insect Cells and Mammalian Cells: These systems are preferred when the protein requires complex post-translational modifications for proper folding or activity. Baculovirus expression in insect cells and transient or stable expression in mammalian cells can provide the necessary modifications .
The efficiency of recombinant protein production can vary significantly depending on the host system and expression conditions. For instance, innovative systems like the vesicle-packaged recombinant protein production from E. coli can achieve high yields of functional proteins, which could be applicable to UPF0283 if similar technologies are adapted .
Given the limited specific data available on recombinant UPF0283 membrane protein VP1870, we can consider general trends in recombinant protein production:
| Host System | Advantages | Yield Considerations |
|---|---|---|
| E. coli | High yield, cost-effective | Can be limited for complex proteins |
| Yeast | High yield, eukaryotic modifications | Similar to E. coli but with some eukaryotic modifications |
| Insect Cells | Complex post-translational modifications | Generally lower yields compared to E. coli or yeast |
| Mammalian Cells | Extensive post-translational modifications | Often the lowest yields but provides authentic modifications |
Future research on recombinant UPF0283 membrane protein VP1870 should focus on elucidating its biological function, exploring its potential applications in biotechnology or medicine, and optimizing its production processes to enhance yield and efficiency. This could involve adapting innovative technologies like vesicle-packaged protein production or improving expression conditions in various host systems.
KEGG: vpa:VP1870
STRING: 223926.VP1870
UPF0283 membrane protein VP1870 (UniProt ID: Q87NJ8) is a full-length (346 amino acid) membrane protein derived from Vibrio parahaemolyticus Serotype O3:K6. It belongs to the UPF0283 protein family, which consists of proteins with currently unknown functions. The protein's membrane localization suggests potential roles in cellular transport, signaling, or structural functions within bacterial cells. The "UPF" designation (Uncharacterized Protein Family) indicates that while the protein has been identified and sequenced, its precise biological function remains to be fully elucidated through ongoing research efforts .
Recombinant UPF0283 membrane protein VP1870 can be expressed and purified from multiple host systems, each offering distinct advantages. Escherichia coli and yeast expression systems provide the highest protein yields and shorter production timeframes, making them ideal for initial characterization studies or when larger quantities are required. For applications requiring proper protein folding and post-translational modifications, expression in insect cells via baculovirus vectors or in mammalian cell systems is recommended, although these typically result in lower yields and longer production times . The choice of expression system should be determined by the specific requirements of your experimental design and downstream applications.
For optimal stability and preservation of biological activity, recombinant VP1870 protein should be stored at -20°C to -80°C upon receipt. The protein requires proper aliquoting for multiple use scenarios to minimize freeze-thaw cycles, which can compromise protein integrity and functionality. For short-term usage within one week, working aliquots can be stored at 4°C. The protein is typically supplied in a stabilized Tris/PBS-based buffer containing 6% Trehalose at pH 8.0, which helps maintain protein stability during storage . These storage recommendations are crucial for maintaining protein quality throughout the research timeline and ensuring consistent experimental results.
The optimal reconstitution protocol for lyophilized VP1870 protein involves several critical steps:
First, briefly centrifuge the vial to bring all contents to the bottom before opening.
Reconstitute the protein using deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL.
Add glycerol to a final concentration between 5-50% (with 50% being standard) to enhance protein stability.
Properly aliquot the reconstituted protein to minimize freeze-thaw cycles.
Store aliquots at -20°C/-80°C for long-term preservation of activity .
This methodical approach ensures maximum recovery of active protein and minimizes potential degradation during the reconstitution process.
When designing experiments to evaluate VP1870 protein function, researchers should implement a structured experimental design that:
For membrane proteins like VP1870, functional studies might include membrane localization assays, protein-protein interaction studies, or comparative analyses across different Vibrio species to elucidate evolutionary conservation and functional significance.
For His-tagged VP1870 protein, immobilized metal affinity chromatography (IMAC) represents the primary purification technique due to the N-terminal His-tag fusion. An effective purification protocol typically involves:
Cell lysis under conditions that preserve protein structure (particularly important for membrane proteins).
Initial capture using Ni-NTA or similar affinity resin with binding buffer containing low imidazole concentrations (10-20 mM).
Washing steps with gradually increasing imidazole concentrations to remove non-specifically bound proteins.
Elution with higher imidazole concentrations (250-500 mM).
Buffer exchange to remove imidazole using dialysis or size-exclusion chromatography.
Quality assessment via SDS-PAGE to verify purity (>90% purity is reported for commercial preparations) .
For membrane proteins like VP1870, inclusion of appropriate detergents throughout the purification process is crucial to maintain protein solubility and native conformation.
The choice of expression system significantly impacts post-translational modifications (PTMs) of VP1870, with important implications for protein function and experimental outcomes:
| Expression System | Post-translational Modifications | Advantages | Limitations |
|---|---|---|---|
| E. coli | Minimal modifications, primarily phosphorylation | Highest yields, faster production | Lack of complex eukaryotic PTMs, potential improper folding |
| Yeast | Moderate glycosylation, phosphorylation | Good yields, some eukaryotic PTMs | Patterns of glycosylation differ from mammalian systems |
| Insect cells (Baculovirus) | More complex PTMs including glycosylation | Better protein folding, many eukaryotic PTMs | Lower yields, longer production time |
| Mammalian cells | Most authentic PTMs | Closest to native protein structure | Lowest yields, longest production time, most costly |
When studying VP1870, researchers should select the expression system based on whether native bacterial PTMs are sufficient or if the experimental design requires specific modifications that might occur in more complex systems . This decision is particularly important for functional studies where protein activity may depend on specific modifications.
To investigate VP1870's membrane topology and structural characteristics, researchers can employ multiple complementary approaches:
Computational prediction tools: Using algorithms like TMHMM, HMMTOP, or Phobius to predict transmembrane regions and topology.
Biochemical mapping techniques:
Cysteine scanning mutagenesis followed by accessibility assays
Protease protection assays to identify exposed regions
Glycosylation mapping using engineered glycosylation sites
Structural biology approaches:
X-ray crystallography (challenging for membrane proteins, may require lipidic cubic phase)
Cryo-electron microscopy (particularly useful for membrane proteins)
NMR spectroscopy for dynamic structural information
Small-angle X-ray scattering (SAXS) for low-resolution structural information
Fluorescence-based techniques:
FRET (Förster Resonance Energy Transfer) to measure distances between domains
GFP-fusion reporter systems to track cellular localization
The purity level of commercially available VP1870 (>90%) makes it suitable for many of these analytical techniques, though additional purification steps may be necessary for high-resolution structural studies.
When designing experiments to identify VP1870 interaction partners, researchers should consider a multi-faceted approach:
Experimental design principles:
Recommended techniques:
Pull-down assays leveraging the His-tag fusion
Co-immunoprecipitation with antibodies against VP1870
Yeast two-hybrid screening (for soluble domains)
Bacterial two-hybrid systems (more suitable for membrane proteins)
Proximity labeling approaches (BioID or APEX)
Cross-linking mass spectrometry
Surface plasmon resonance for quantitative binding studies
Validation strategies:
Reverse pull-down experiments
Co-localization studies in bacterial cells
Functional assays to demonstrate biological relevance of interactions
Mutagenesis to identify critical interaction interfaces
The His-tagged nature of recombinant VP1870 provides an immediate advantage for affinity-based methods, enabling specific capture of the protein and its interacting partners.
Researchers working with recombinant VP1870 may encounter several challenges, with corresponding solutions:
| Challenge | Possible Causes | Recommended Solutions |
|---|---|---|
| Low protein solubility | Hydrophobic membrane protein nature | Optimize detergent type and concentration; consider using milder detergents like DDM or LMNG |
| Protein aggregation | Improper folding, concentration too high | Reduce protein concentration; add stabilizing agents; optimize buffer conditions |
| Loss of activity after storage | Protein degradation, denaturation | Strictly follow storage recommendations; avoid freeze-thaw cycles; add protease inhibitors |
| Inconsistent experimental results | Batch-to-batch variation | Use proteins from the same production lot for complete experimental series; implement rigorous quality control |
| Interference with downstream assays | His-tag affecting protein function | Consider tag removal using appropriate proteases; validate function with and without tag |
Adhering to proper storage conditions (-20°C/-80°C) and handling procedures is crucial for maintaining protein integrity and experimental reproducibility . Additionally, working aliquots should be stored at 4°C for no longer than one week to prevent activity loss.
To ensure high-quality VP1870 protein preparations for reliable experimental outcomes, researchers should implement a comprehensive quality control protocol:
Purity assessment:
Structural integrity:
Circular dichroism spectroscopy to assess secondary structure
Thermal shift assays to evaluate protein stability
Dynamic light scattering to check for aggregation
Functional validation:
Binding assays with known ligands if available
Membrane incorporation studies using liposomes
Activity assays based on predicted function (may require development)
Storage stability monitoring:
Comparative analysis of fresh vs. stored samples
Regular testing of stored aliquots at defined time points
Documentation of protein behavior under various storage conditions
Implementing these quality control measures helps ensure that experimental variations reflect true biological phenomena rather than differences in protein preparation quality.
Despite available structural and expression information, several knowledge gaps remain in VP1870 research that merit scientific investigation:
Functional characterization: As a member of the UPF0283 family, the specific biological function of VP1870 remains largely unknown, presenting opportunities for functional genomics approaches.
Structural determinants: While amino acid sequence data is available , high-resolution structural information is lacking, limiting our understanding of structure-function relationships.
Interaction network: The protein-protein interaction landscape of VP1870 within Vibrio parahaemolyticus remains unexplored, representing a significant knowledge gap.
Role in bacterial physiology: How VP1870's membrane localization contributes to cellular processes and bacterial survival requires elucidation.
Evolutionary conservation: Comparative analysis across Vibrio species and related bacteria could provide insights into functional importance and specialization.
These knowledge gaps present promising avenues for researchers to contribute meaningful advances to the understanding of this membrane protein's biological significance.
Several cutting-edge technologies and approaches hold promise for advancing VP1870 research:
Structural biology innovations:
Advances in cryo-electron microscopy for membrane protein structure determination
Integrative structural biology combining multiple data sources
AlphaFold2 and other AI-based structure prediction methods
Functional genomics approaches:
CRISPR interference/activation for functional studies in bacterial systems
High-throughput phenotypic screening using bacterial mutant libraries
Transposon sequencing (Tn-Seq) to identify genetic interactions
Single-cell technologies:
Single-cell transcriptomics to understand expression patterns
Super-resolution microscopy for precise localization studies
FRET-based biosensors to monitor protein dynamics
Systems biology integration:
Multi-omics data integration to place VP1870 in biological context
Network analysis to identify functional modules
Computational modeling of membrane protein dynamics
These emerging technologies promise to overcome current technical limitations and provide deeper insights into the structure, function, and biological significance of VP1870, potentially revealing unexpected roles in bacterial physiology or pathogenesis.